IFNA1 and neoplasm: In this line, a combined therapy of recombinant IFN-α with poxvirus vaccines targeting pancreatic adenocarcinomas slowed tumor growth, induced cytotoxic lymphocyte activity, and increased CD8+ tumor-infiltrating lymphocytes [32].